STERIS plc (NYSE:STE) Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC cut its stake in STERIS plc (NYSE:STE - Free Report) by 49.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 51,827 shares of the medical equipment provider's stock after selling 51,720 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.05% of STERIS worth $10,654,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. grew its holdings in shares of STERIS by 9.5% during the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock worth $270,230,000 after buying an additional 96,336 shares in the last quarter. Daiwa Securities Group Inc. grew its stake in STERIS by 10.3% during the 3rd quarter. Daiwa Securities Group Inc. now owns 13,724 shares of the medical equipment provider's stock valued at $3,329,000 after acquiring an additional 1,276 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in STERIS by 2.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 43,253 shares of the medical equipment provider's stock valued at $10,491,000 after acquiring an additional 1,053 shares during the last quarter. Public Sector Pension Investment Board lifted its stake in STERIS by 13.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock worth $1,039,000 after purchasing an additional 500 shares in the last quarter. Finally, Eventide Asset Management LLC lifted its stake in STERIS by 8.6% in the 3rd quarter. Eventide Asset Management LLC now owns 143,459 shares of the medical equipment provider's stock worth $34,795,000 after purchasing an additional 11,362 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on STE shares. Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Stephens reaffirmed an "overweight" rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities reiterated a "market outperform" rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, STERIS currently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Trading Up 1.9 %

STE traded up $4.14 during trading hours on Monday, reaching $227.14. The company's stock had a trading volume of 584,196 shares, compared to its average volume of 527,809. The business's 50-day moving average is $222.86 and its 200-day moving average is $221.01. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The stock has a market cap of $22.32 billion, a PE ratio of 48.22 and a beta of 0.92. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. STERIS's dividend payout ratio is presently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.